MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$506,361K
Cash and cash
equivalents
$159,859K
Prepaid expenses and
other current assets
$6,718K
Other receivables
$4,609K
Total property and
equipment, at cost
$58,053K
Total current assets
$677,547K
Property and equipment,
net
$28,409K
Operating lease
right-of-use assets
$24,693K
Restricted cash
$4,947K
Other long-term
assets
$832K
Less accumulated
depreciation
$29,644K
Total assets
$736,428K
Total liabilities and
stockholders' equity
$736,428K
Total stockholders'
equity
$521,916K
Total liabilities
$214,512K
Accumulated deficit
-$521,717K
Accumulated other
comprehensive loss
-$4,746K
Additional paid-in capital
$1,048,371K
Deferred revenue, net of
current
$103,635K
Total current
liabilities
$71,036K
Operating lease
liability, net of current
$34,581K
Defined benefit plan
liability
$5,260K
Common stock, 0.0001
par value...
$8K
Current deferred
revenue
$33,059K
Accrued expenses and
other current...
$25,594K
Accounts payable
$7,900K
Current portion of
operating lease liability
$4,483K
Back
Back
Balance Sheet
Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. (GLUE)
source: myfinsight.com